NK-92MIhCD64 (Q54930661)

From Wikidata

Jump to navigation Jump to search

cell line

Language	Label	Description	Also known as
English	NK-92MIhCD64	cell line

Statements

1 reference

Cellosaurus release 44

27 January 2023

cancer cell line

1 reference

Cellosaurus release 44

27 January 2023

parent cell line

1 reference

Cellosaurus release 44

27 January 2023

described by source

Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody

1 reference

Cellosaurus release 44

27 January 2023

established from medical condition

natural killer cell lymphoblastic leukemia/lymphoma

1 reference

Cellosaurus release 44

27 January 2023

derived from organism type

1 reference

Cellosaurus release 44

27 January 2023

Identifiers

1 reference

Cellosaurus release 44

27 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54930661&oldid=1861674052"